EFFICACY OF CLONAZEPAM AND NORTRIPTYLINE IN THE MANAGEMENT OF BURNING MOUTH SYNDROME: A COMPARATIVE STUDY

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2019, Vol 6, Issue 28

Abstract

BACKGROUND Burning mouth syndrome (BMS) is a syndrome with intra oral burning sensation without clinical cause which occurs daily for more than 2 hours per day persisting for more than 3 months, which may be associated with taste alteration and oral dryness. The etiopathogenesis of BMS remains elusive and the most accepted theory suggests a neuropathic pain condition involved with neurotransmitter GABA in the gustatory system. Clonazepam-GABA agonist has been used in clinical practices for BMS. Nortriptyline, a TCA inhibits the reuptake of serotonin and norepinephrine into the synapse, thereby enhancing signalling via these neurotransmitters and thus used in neuropathic pain of BMS. METHODS 72 patients of VIMSAR ENT OPD complained of burning mouth sensation without any oral or general pathology and diagnosed as BMS from September 2017 to February 2019 were included in the study. 36 patients were prescribed clonazepam and other 36 patients were treated with nortriptyline. Clinical evaluation after 6 wks. and 3 months of treatment was done and pain evaluated with verbal numerical scale (VNS). RESULTS Out of 72 patients, 46 were males and the mean age of presentation was 66 years. At the time of presentation, the mean baseline VNS score for the group (n=36) treated with clonazepam was 7.1 ± 0.9 and for the group (n=36) treated with nortriptyline was 6.8 ± 1.2. After treatment, VNS scores were 4.7 ± 1.3 and 4.5 ± 0.9 respectively at 6 weeks (p=0.510) and 3.3 ± 1.3 and 2.5 ± 0.9 respectively at the end of 3 months (p=0.499). CONCLUSIONS Nortriptyline is a better drug than Clonazepam for management of pain in patients with BMS

Authors and Affiliations

Souvagini Acharya, Himanshu Mishra, Rashmita Nayak, Nirupama Pati

Keywords

Related Articles

HYDRALAZINE? ESSENTIAL OR HAS A POTENTIAL FOR COMPLICATIONS IN DERMATOLOGY

: BACKGROUND: Hydralazine is a drug which is vasodilator, it lowers blood pressure and allows blood to flow more easily in veins and arteries. Hydralazine is used to treat hypertension. OBJECTIVES: The purpose of this pr...

ROLE OF MRI IN ROTATOR CUFF INJURIES

BACKGROUND Rotator cuff unit plays an important role in the normal functioning of the shoulder joint and any injury to these muscles will lead to potential clinical consequences. Hence, it is necessary to understand its...

A RARE CASE OF BILATERAL MICROSPHEREPHAKIA

Microspherophakia is rare bilateral congenital anamoly of the crystalline lens. The condition may be isolated, familial or it may be associated with systemic affections like Marfan's syndrome, Weil-Marchesani syndrome, h...

BACTERIAL PROFILE IN BURN WOUNDS WITH SPECIAL REFERENCE TO ANTIMICROBIAL AGENTS AND TOPICAL APPLICATIONS IN A TERTIARY CARE HOSPITAL- A 2 YEAR PROSPECTIVE STUDY

BACKGROUND Burn is one of the most devastating condition. It is seen in all age groups from a baby to the elderly. Burn injuries pose a big challenge to the medical fraternity. Burn injuries can have an effect on the ski...

RIVES AND LICHTENSTEIN REPAIR IN INGUINAL HERNIA- A COMPARISON OF POSTOPERATIVE COMPLICATIONS TO KNOW WHETHER RIVES REPAIR IS AS SAFE AS THE GOLD STANDARD LICHTENSTEIN REPAIR

BACKGROUND Hernia repair surgeries underwent a lot of modifications over time. These modifications were an attempt to reduce the recurrence rate and post-operative complications. Current techniques for Inguinal hernia sh...

Download PDF file
  • EP ID EP668619
  • DOI 10.18410/jebmh/2019/385
  • Views 79
  • Downloads 0

How To Cite

Souvagini Acharya, Himanshu Mishra, Rashmita Nayak, Nirupama Pati (2019). EFFICACY OF CLONAZEPAM AND NORTRIPTYLINE IN THE MANAGEMENT OF BURNING MOUTH SYNDROME: A COMPARATIVE STUDY. Journal of Evidence Based Medicine and Healthcare, 6(28), 1892-1895. https://europub.co.uk/articles/-A-668619